CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

The Future of CRT Depends on Stronger Grassroots Advocacy Now thumbnail The Future of CRT Depends on Stronger Grassroots Advocacy Now The future of CRT access depends on broader industry and grassroots advocacy to defend reimbursement, influence policy, and improve patient access to care. Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement thumbnail Unlearning Is Harder Than Learning—Especially in Billing & Reimbursement Outdated billing & reimbursement habits can increase audit risk. Learn why DME suppliers must unlearn assumptions, validate guidance, & strengthen compliance. DMEPOS Accreditation in 2026: How to Stay Compliant thumbnail DMEPOS Accreditation in 2026: How to Stay Compliant CMS's new accreditation requirements are raising the stakes for DMEPOS providers. VGM's Annual Accreditation Guide helps providers simplify their accreditation journey. HME Industry Growth, Medicare Advantage, & Competitive Bidding thumbnail HME Industry Growth, Medicare Advantage, & Competitive Bidding Explore key HME industry trends, including DMEPOS growth, Medicare Advantage, competitive bidding, and what providers need to know to stay competitive. Building the Next Generation of O&P Advocates Starts Now thumbnail Building the Next Generation of O&P Advocates Starts Now The future of independent O&P depends on strong advocates. See how OPGA is helping develop future leaders through mentorship, education, and advocacy. The Friction Audit thumbnail The Friction Audit Not all friction is bad. Learn how the right balance of speed, process, and thoughtful decision-making can help healthcare organizations thrive. Turning Home Access Into a Scalable Growth Strategy thumbnail Turning Home Access Into a Scalable Growth Strategy Home accessibility is evolving into a scalable, service-driven growth opportunity for DME providers. Pinnacle Mobility: Advancing Mobility Solutions | VGM Member Spotlight thumbnail Pinnacle Mobility: Advancing Mobility Solutions | VGM Member Spotlight Pinnacle Mobility delivers personalized complex rehab technology and mobility equipment solutions in Southern California, improving independence and quality of life.